GlassScriptPhysician profile
Aaryn R Drinkwater
NPI 1922202621
$1,470.00
in general payments reported to CMS, 2019-2025
18 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.00 · 2022: $13.10 · 2023: $248 · 2024: $809 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,394.52 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $218.33 | 2023-2025 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $193.27 | 2024-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Jazz Pharmaceuticals INC. | $191.32 | 2021-2025 | |
| Harmony Biosciences LLC | $183.50 | 2023-2025 | Wakix |
| Axsome Therapeutics, INC. | $124.36 | 2023-2025 | Sunosi |
| Genzyme Corporation | $108.45 | 2024-2025 | |
| Intuitive Surgical, INC. | $106.91 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.77 | 2024-2025 | Ofev |
| Inspire Medical Systems, INC. | $45.98 | 2024-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $42.82 | 2024 | Lumryz |
| Merck Sharp & Dohme LLC | $40.33 | 2023 | Belsomra |
| United Therapeutics Corporation | $28.55 | 2024 | Tyvaso |
| Mylan Specialty L.P. | $25.91 | 2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $21.98 | 2024 | Dupixent |
| Verona Pharma, INC. | $21.50 | 2025 | Ohtuvayre |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $20.54 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
| Philips North America LLC | $13.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaryn Drinkwater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.